Irritable bowel syndrome (IBS) is a common, chronic functional gastrointestinal disorder
affecting the large intestine, and presents as abdominal pain and/or discomfort, bloating, gas …

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder that is
characterized by the presence of abdominal pain or discomfort and is subtyped by the …

Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
disorder that affects 9%-23% of the population across the world. The percentage of patients …

Irritable bowel syndrome (IBS) is a very common functional gastrointestinal disorder
characterized by abdominal pain or discomfort with bowel habit changes. However, its …

The Rome criteria are universally used as inclusion criteria in pharmaceutical clinical trials
and have therefore contributed to testing of several irritable bowel syndrome (IBS)-specific …

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disease with a
significant impact on patients' quality of life and a high socioeconomic burden. And the …

Functional gastrointestinal disorders (FGIDs) account for at least 40% of all referrals to
gastroenterologists. Of the 33 recognized adult FGIDs, irritable bowel syndrome (IBS) is the …

A decade after Rome III, in 2016, Rome IV criteria were published. There are major
differences between Rome IV and the earlier iteration, some of which are in line with Asian …

Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis,
which affects approximately 4% of the global population. The Rome IV criteria define IBS as …

Functional gastrointestinal disorders (FGIDs) are diagnosed and classified using the Rome
criteria; the criteria may change over time as new scientific data emerge. The Rome IV was …